For help on how to get the results you want, see our search tips.
122 results
-
List item
Summary of opinion: Translarna (updated)
ataluren, opinion date: 27/06/2019, Negative, Last updated: 26/07/2019 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate / umeclidinium / vilanterol, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Venclyxto
venetoclax, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Xarelto
rivaroxaban, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Symkevi
tezacaftor / ivacaftor, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Repatha
evolocumab, opinion date: 22/03/2018, Positive, Last updated: 23/03/2018 -
List item
Summary of opinion: Macimorelin Aeterna Zentaris
macimorelin, opinion date: 15/11/2018, Positive, Last updated: 16/11/2018 -
List item
Summary of opinion: Rubraca
rucaparib, opinion date: 13/12/2018, Positive, Last updated: 14/12/2018 -
List item
Summary of opinion: Adcetris
brentuximab vedotin, opinion date: 13/12/2018, Positive, Last updated: 14/12/2018 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 31/01/2019, Positive, Last updated: 01/02/2019 -
List item
Summary of opinion: Hemlibra
emicizumab, opinion date: 31/01/2019, Positive, Last updated: 01/02/2019 -
List item
Summary of opinion: Grasustek
pegfilgrastim, opinion date: 26/04/2019, Positive, Last updated: 26/04/2019 -
List item
Summary of opinion: Dupixent
dupilumab, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Cyramza
ramucirumab, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Fiasp
insulin aspart, opinion date: 27/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Lonsurf
trifluridine / tipiracil, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Zerbaxa
ceftolozane / tazobactam, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Empliciti
elotuzumab, opinion date: 25/07/2019, Positive, Last updated: 25/07/2019 -
List item
Summary of opinion: Keytruda
pembrolizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Orphan designation: Glyceryl tri-(4-phenylbutyrate) for: Treatment of hyperargininaemia
Date of first decision: 10/06/2010, Positive, Last updated: 12/07/2019 -
List item
Orphan designation: Glyceryl tri-(4-phenylbutyrate) for: Ornithine translocase deficiency (hyperornithinaemia-hyperammonaemia homocitrullinuria (HHH) syndrom
Date of first decision: 10/06/2010, Positive, Last updated: 12/07/2019 -
List item
Orphan designation: Glyceryl tri-(4-phenylbutyrate) for: Treatment of argininosuccinic aciduria
Date of first decision: 10/06/2010, Positive, Last updated: 12/07/2019 -
List item
Orphan designation: Glyceryl tri-(4-phenylbutyrate) for: Treatment of citrullinaemia type 1
Date of first decision: 10/06/2010, Positive, Last updated: 12/07/2019